PT777491E - Utilizacao de colagenio hidrolisado, de sabor neutro e agente que o contem - Google Patents

Utilizacao de colagenio hidrolisado, de sabor neutro e agente que o contem

Info

Publication number: PT777491E
Authority: PT; Portugal
Prior art keywords: pct; agent; osteoporosis; gelatin; sec
Prior art date: 1994-08-23

Application number

PT95929893T

Other languages

English (en)

Inventor

Milan Adam

Eggersgluess Bernd

Braeumer Klaus

Schrieber Reinhard

Original Assignee

Stoess & Co Gelatine

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-23

Filing date

1995-08-19

Publication date

2005-01-31

1995-08-19 Application filed by Stoess & Co Gelatine filed Critical Stoess & Co Gelatine

2005-01-31 Publication of PT777491E publication Critical patent/PT777491E/pt

Links

239000003795 chemical substances by application Substances 0.000 title abstract 3
102000008186 Collagen Human genes 0.000 title abstract 2
108010035532 Collagen Proteins 0.000 title abstract 2
229920001436 collagen Polymers 0.000 title abstract 2
239000000796 flavoring agent Substances 0.000 title 1
235000019634 flavors Nutrition 0.000 title 1
230000007935 neutral effect Effects 0.000 title 1
108010010803 Gelatin Proteins 0.000 abstract 2
208000001132 Osteoporosis Diseases 0.000 abstract 2
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
229920000159 gelatin Polymers 0.000 abstract 2
239000008273 gelatin Substances 0.000 abstract 2
235000019322 gelatine Nutrition 0.000 abstract 2
235000011852 gelatine desserts Nutrition 0.000 abstract 2
102000055006 Calcitonin Human genes 0.000 abstract 1
108060001064 Calcitonin Proteins 0.000 abstract 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
229960004015 calcitonin Drugs 0.000 abstract 1
159000000007 calcium salts Chemical class 0.000 abstract 1
210000002808 connective tissue Anatomy 0.000 abstract 1
229960003387 progesterone Drugs 0.000 abstract 1
239000000186 progesterone Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Orthopedic Medicine & Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Seasonings (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Cosmetics (AREA)

PT95929893T 1994-08-23 1995-08-19 Utilizacao de colagenio hidrolisado, de sabor neutro e agente que o contem PT777491E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4429842		1994-08-23

Publications (1)

Publication Number	Publication Date
PT777491E true PT777491E (pt)	2005-01-31

Family

ID=6526329

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT95929893T PT777491E (pt)	1994-08-23	1995-08-19	Utilizacao de colagenio hidrolisado, de sabor neutro e agente que o contem

Country Status (12)

Country	Link
US (1)	US5948766A (pt)
EP (1)	EP0777491B1 (pt)
JP (1)	JPH10504555A (pt)
AT (1)	ATE282423T1 (pt)
AU (1)	AU703137B2 (pt)
CA (1)	CA2198099C (pt)
DE (1)	DE59510968D1 (pt)
ES (1)	ES2233947T3 (pt)
FI (1)	FI118513B (pt)
NO (1)	NO318182B1 (pt)
PT (1)	PT777491E (pt)
WO (1)	WO1996005851A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4609807B2 (ja) *	1996-03-28	2011-01-12	雪印乳業株式会社	骨強化用医薬、飲食品及び飼料
JPH1112192A (ja) *	1997-06-18	1999-01-19	Zenyaku Kogyo Kk	骨粗鬆症予防・治療剤
US20050208114A1 (en) *	1998-03-24	2005-09-22	Petito George D	Composition and method for healing tissues
US7691829B2 (en) *	1998-03-24	2010-04-06	Petito George D	Composition and method for healing tissues
JP2009148275A (ja) *	2000-08-30	2009-07-09	Morisuke Yokoyama	特定保健用食品
ITRM20010380A1 (it) *	2001-07-02	2003-01-02	Bioprogress Spa	Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
JP4766818B2 (ja) *	2002-07-24	2011-09-07	隆文小濱	妊娠時に特異的な腰痛、股関節痛及び鼠径部痛の改善・治療剤
DE10339180A1 (de) *	2003-08-21	2005-03-24	Deutsche Gelatine-Fabriken Stoess Ag	Kollagenhydrolysat
WO2006112012A1 (ja) *	2005-04-13	2006-10-26	Snow Brand Milk Products Co., Ltd.	栄養組成物
US8187639B2 (en)	2005-09-27	2012-05-29	Tissue Tech, Inc.	Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
WO2007038686A2 (en)	2005-09-27	2007-04-05	Tissuetech, Inc.	Amniotic membrane preparations and purified compositions and methods of use
ES2288791B1 (es) *	2006-02-10	2008-12-01	Masterfarm, S.L.	Procedimiento de obtencion de un hidrolizado de colageno. hidrolizado enzimatico de colageno obtenible por el procedimiento y usos del mismo.
ES2298071B1 (es) *	2006-10-25	2009-07-28	Masterfarm,S.L.	Hidrolizado enzimatico de colageno y procedimiento de obtencion.
US20100113368A1 (en) *	2007-03-21	2010-05-06	Luppo Edens	Cholesterol lowering protein hydrolysates
JP2008231065A (ja) *	2007-03-23	2008-10-02	Chisso Corp	骨代謝改善剤
US20110312928A1 (en) *	2010-06-18	2011-12-22	Lipocine Inc.	Progesterone Containing Oral Dosage Forms and Related Methods
US9375437B2 (en)	2010-06-18	2016-06-28	Lipocine Inc.	Progesterone containing oral dosage forms and kits
DE102011000997A1 (de) *	2011-03-01	2012-09-06	Gelita Ag	Zusammensetzung für Ernährungszwecke
US9526770B2 (en)	2011-04-28	2016-12-27	Tissuetech, Inc.	Methods of modulating bone remodeling
US8951996B2 (en)	2011-07-28	2015-02-10	Lipocine Inc.	17-hydroxyprogesterone ester-containing oral compositions and related methods
DE102012110612A1 (de)	2012-11-06	2014-05-08	Gelita Ag	Kollagenhydrolysat und dessen Verwendung
CA2937613C (en)	2013-01-23	2021-03-02	Bottled Science Limited	Skin enhancing beverage composition
WO2016210003A2 (en)	2015-06-22	2016-12-29	Lipocine Inc.	17-hydroxyprogesterone ester-containing oral compositions and related methods
TW201733600A (zh)	2016-01-29	2017-10-01	帝聖工業公司	胎兒扶持組織物及使用方法
US11110147B2 (en)	2017-03-15	2021-09-07	Rousselot B.V	Collagen hydrolysates as a beneficial prebiotic and their effect on joint inflammation and osteoarthritis
DE102019202606A1 (de)	2018-11-06	2020-05-07	Gelita Ag	Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung
DE102020126594A1 (de) *	2020-10-09	2022-04-14	Gelita Ag	Kollagenhydrolysat als Wirkstoff zum Verzögern der Alterung
DE102021119031B4 (de)	2021-07-22	2024-08-08	Manfred Lotz	Behandlung von Polymyalgia Rheumatica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1227534A (pt) *	1967-08-31	1971-04-07
CA1302880C (en) *	1986-07-25	1992-06-09	Peter Koepff	Agents for the treatment of arthroses
DE3626414C2 (de) *	1986-08-05	1994-11-10	Robapharm Ag	Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
CN1045719C (zh) *	1993-04-10	1999-10-20	北京市西城区华新生化技术研究所	口服接骨和治骨质疏松液
US5641747A (en) *	1994-07-25	1997-06-24	Temple University-Of The Commonwealth System Of Higher Education	Treatment of osteopetrotic diseases

1995
- 1995-08-19 DE DE59510968T patent/DE59510968D1/de not_active Expired - Lifetime
- 1995-08-19 AU AU33470/95A patent/AU703137B2/en not_active Ceased
- 1995-08-19 AT AT95929893T patent/ATE282423T1/de active
- 1995-08-19 JP JP8507790A patent/JPH10504555A/ja active Pending
- 1995-08-19 ES ES95929893T patent/ES2233947T3/es not_active Expired - Lifetime
- 1995-08-19 WO PCT/EP1995/003304 patent/WO1996005851A1/de not_active Ceased
- 1995-08-19 CA CA002198099A patent/CA2198099C/en not_active Expired - Fee Related
- 1995-08-19 EP EP95929893A patent/EP0777491B1/de not_active Expired - Lifetime
- 1995-08-19 PT PT95929893T patent/PT777491E/pt unknown
- 1995-08-19 US US08/793,252 patent/US5948766A/en not_active Expired - Lifetime
1997
- 1997-02-19 FI FI970703A patent/FI118513B/fi active IP Right Grant
- 1997-02-21 NO NO19970805A patent/NO318182B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI970703L (fi)	1997-02-19
EP0777491A1 (de)	1997-06-11
EP0777491B1 (de)	2004-11-17
NO970805D0 (no)	1997-02-21
US5948766A (en)	1999-09-07
ATE282423T1 (de)	2004-12-15
ES2233947T3 (es)	2005-06-16
DE59510968D1 (de)	2004-12-23
WO1996005851A1 (de)	1996-02-29
NO970805L (no)	1997-02-21
NO318182B1 (no)	2005-02-14
AU3347095A (en)	1996-03-14
AU703137B2 (en)	1999-03-18
JPH10504555A (ja)	1998-05-06
CA2198099A1 (en)	1996-02-29
CA2198099C (en)	2001-01-16
FI118513B (fi)	2007-12-14
FI970703A0 (fi)	1997-02-19

Publication	Publication Date	Title
PT777491E (pt)	2005-01-31	Utilizacao de colagenio hidrolisado, de sabor neutro e agente que o contem
PT831882E (pt)	2005-01-31	Composicoes de segmentos de fibra de colagenio reconstituido e metodos de preparacao das mesmas
IS1724B (is)	1999-09-06	Aðferð við meðhöndlun á ígræðlingi úr málmi fyrirskurðaðgerð
FI970101A0 (fi)	1997-01-10	Uusi farmaseuttinen valmiste kivun hallintaan
ES2149775T3 (es)	2000-11-16	Composicion para el tratamiento de tejidos que comprende fibrina o fibrinogeno y un polimero biodegradable y biocompatible.
CA2223172A1 (en)	1996-12-12	Methods and compositions for use against dental calculus in domestic animals
DE69526937D1 (de)	2002-07-11	Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
PT920323E (pt)	2003-11-28	Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
EA199700032A1 (ru)	1997-12-30	Дезинфицирующий состав "велтолен"
NO982721D0 (no)	1998-06-12	Preserverende oppl°sning
BR9509975A (pt)	1998-06-09	Formulação farmacêutica
NZ506681A (en)	2002-12-20	Disinfecting composition
NO971182D0 (no)	1997-03-14	Anvendelse av 2,4-diaminopyrimidin-3-oksyd eller et salt derav for behandling av maturasjons- og struktureringsforstyrrelser av kollagen
CA2230307A1 (en)	1998-01-08	Aquatic animal treatment method and composition containing cajeput oil
BR9507495A (pt)	1997-08-12	Bala para chupar com acão neutralizadora da placa dentária
DE59408645D1 (de)	1999-09-23	Lactulose-pastillen
ES2140576T3 (es)	2000-03-01	Composicion para la piel que contiene sauco.
CO5070608A1 (es)	2001-08-28	Metodo para aumentar la permeabilidad del tejido corneo humano
ATE208204T1 (de)	2001-11-15	Flüssigkeitsersatzlösung
EA199800953A1 (ru)	1999-04-29	Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
GB9723630D0 (en)	1998-01-07	M.vaccae preparation and its use
DE69606627D1 (de)	2000-03-16	Pharmazeutische zusammensetzungen zur polarisationsregulierung der einheitlichen glatten muskeln